| scholarly article | Q13442814 |
| P50 | author | Myron M. Levine | Q29564379 |
| P2093 | author name string | Stefanie N Vogel | |
| Araceli E Santiago | |||
| Eileen M Barry | |||
| Leah E Cole | |||
| Augusto Franco | |||
| P2860 | cites work | The complete genome sequence of Francisella tularensis, the causative agent of tularemia | Q22122045 |
| A method for allelic replacement in Francisella tularensis | Q40644619 | ||
| Aerogenic immunization of man with live Tularemia vaccine | Q40720507 | ||
| AEROSOL INFECTION OF MAN WITH PASTEURELLA TULARENSIS | Q41008144 | ||
| From rabbits to humans: the contributions of Dr. Theodore E. Woodward to tularemia research | Q43222729 | ||
| Francisella tularensis selectively induces proinflammatory changes in endothelial cells | Q47677588 | ||
| The Francisella tularensis pathogenicity island protein IglC and its regulator MglA are essential for modulating phagosome biogenesis and subsequent bacterial escape into the cytoplasm. | Q50763785 | ||
| Prophylactic effectiveness of live and killed tularemia vaccines. I. Production of vaccine and evaluation in the white mouse and guinea pig. | Q54181225 | ||
| Genetic tools for highly pathogenic Francisella tularensis subsp. tularensis. | Q54452752 | ||
| Immunization against tularemia: analysis of the effectiveness of live Francisella tularensis vaccine in prevention of laboratory-acquired tularemia | Q67541973 | ||
| Transformation and allelic replacement in Francisella spp | Q67859396 | ||
| Cytokine expression in the liver of mice infected with a highly virulent strain of Francisella tularensis | Q71661744 | ||
| Electroporation of Francisella tularensis | Q71722151 | ||
| Regulation of lipopolysaccharide sensitivity by IFN regulatory factor-2 | Q73419660 | ||
| Safety and immunogenicity of CVD 1208S, a live, oral DeltaguaBA Deltasen Deltaset Shigella flexneri 2a vaccine grown on animal-free media | Q81445405 | ||
| Identification of an essential Francisella tularensis subsp. tularensis virulence factor | Q30439303 | ||
| Francisella tularensis subsp. tularensis Schu S4 disulfide bond formation protein B, but not an RND-type efflux pump, is required for virulence | Q30440960 | ||
| Preliminary analysis and annotation of the partial genome sequence of Francisella tularensis strain Schu 4. | Q30726013 | ||
| Construction of a reporter plasmid for screening in vivo promoter activity in Francisella tularensis | Q30772154 | ||
| A Francisella tularensis Schu S4 purine auxotroph is highly attenuated in mice but offers limited protection against homologous intranasal challenge | Q33346284 | ||
| Rapid local expression of interleukin-12, tumor necrosis factor alpha, and gamma interferon after cutaneous Francisella tularensis infection in tularemia-immune mice | Q34000875 | ||
| Internalization and phagosome escape required for Francisella to induce human monocyte IL-1beta processing and release | Q34248184 | ||
| Toll-like receptor 2 is required for inflammatory responses to Francisella tularensis LVS | Q34601931 | ||
| Tularemia: history, epidemiology, pathogen physiology, and clinical manifestations | Q34613846 | ||
| Cytokine expression in the liver during the early phase of murine tularemia. | Q35385119 | ||
| Characterization of the nucleotide sequence of the groE operon encoding heat shock proteins chaperone-60 and -10 of Francisella tularensis and determination of the T-cell response to the proteins in individuals vaccinated with F. tularensis | Q35546862 | ||
| The immunologically distinct O antigens from Francisella tularensis subspecies tularensis and Francisella novicida are both virulence determinants and protective antigens | Q35689103 | ||
| Virulence comparison in mice of distinct isolates of type A Francisella tularensis | Q35792914 | ||
| Toll-like receptor 2-mediated signaling requirements for Francisella tularensis live vaccine strain infection of murine macrophages | Q35949677 | ||
| Vaccination strategies for Francisella tularensis | Q36140889 | ||
| Type I interferon signaling is required for activation of the inflammasome during Francisella infection | Q36229342 | ||
| Francisella tularensis vaccines | Q36742723 | ||
| Francisella tularensis: activation of the inflammasome | Q36774974 | ||
| Genetics and genetic manipulation in Francisella tularensis | Q36774980 | ||
| Uptake and intracellular fate of Francisella tularensis in human macrophages | Q36792201 | ||
| Francisella tularensis genomics and proteomics | Q36792217 | ||
| In vivo modulation of the murine immune response to Francisella tularensis LVS by administration of anticytokine antibodies | Q36953816 | ||
| Macrophage proinflammatory response to Francisella tularensis live vaccine strain requires coordination of multiple signaling pathways | Q37088323 | ||
| An improved vaccine for prevention of respiratory tularemia caused by Francisella tularensis SchuS4 strain | Q37120769 | ||
| In Vitro Interactions Between Rabbit Alveolar Macrophages and Pasteurella tularensis | Q37389749 | ||
| Deletion in the Shigella enterotoxin genes further attenuates Shigella flexneri 2a bearing guanine auxotrophy in a phase 1 trial of CVD 1204 and CVD 1208. | Q39146446 | ||
| In vivo clearance of an intracellular bacterium, Francisella tularensis LVS, is dependent on the p40 subunit of interleukin-12 (IL-12) but not on IL-12 p70. | Q39654574 | ||
| An attenuated strain of the facultative intracellular bacterium Francisella tularensis can escape the phagosome of monocytic cells | Q39913009 | ||
| Growth of Francisella spp. in rodent macrophages. | Q40151869 | ||
| Innate immune response to Francisella tularensis is mediated by TLR2 and caspase-1 activation | Q40245886 | ||
| Immunologic consequences of Francisella tularensis live vaccine strain infection: role of the innate immune response in infection and immunity | Q40278110 | ||
| Grey variants of the live vaccine strain of Francisella tularensis lack lipopolysaccharide O-antigen, show reduced ability to survive in macrophages and do not induce protective immunity in mice | Q40356819 | ||
| Allelic exchange in Francisella tularensis using PCR products | Q40606566 | ||
| Construction and characterization of a highly efficient Francisella shuttle plasmid | Q40622839 | ||
| P433 | issue | 18 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | vaccine | Q134808 |
| Francisella tularensis | Q1003460 | ||
| attenuated vaccine | Q1810913 | ||
| P304 | page(s) | 2426-2436 | |
| P577 | publication date | 2009-03-03 | |
| P1433 | published in | Vaccine | Q7907941 |
| P1476 | title | Characterization of rationally attenuated Francisella tularensis vaccine strains that harbor deletions in the guaA and guaB genes | |
| P478 | volume | 27 |
| Q33801151 | A Yersinia pestis guaBA mutant is attenuated in virulence and provides protection against plague in a mouse model of infection |
| Q57805360 | Aerosol prime-boost vaccination provides strong protection in outbred rabbits against virulent type A Francisella tularensis |
| Q57915185 | Attenuated Bacterial Vaccines |
| Q83831171 | BALB/c mice, but not C57BL/6 mice immunized with a ΔclpB mutant of Francisella tularensis subspecies tularensis are protected against respiratory challenge with wild-type bacteria: association of protection with post-vaccination and post-challenge i |
| Q40121791 | Benzoxazoles, phthalazinones, and arylurea-based compounds with IMPDH-independent antibacterial activity against Francisella tularensis. |
| Q30299919 | Characterization of Francisella tularensis Schu S4 defined mutants as live-attenuated vaccine candidates |
| Q37073234 | De Novo Guanine Biosynthesis but Not the Riboswitch-Regulated Purine Salvage Pathway Is Required for Staphylococcus aureus Infection In Vivo |
| Q27674590 | De novo GTP Biosynthesis Is Critical for Virulence of the Fungal Pathogen Cryptococcus neoformans |
| Q50133614 | Deletion of the Major Facilitator Superfamily Transporter fptB Alters Host Cell Interactions and Attenuates Virulence of Type A Francisella tularensis |
| Q42732054 | Exploitation of host cell biology and evasion of immunity by francisella tularensis |
| Q47131278 | Gene replacement and quantitative mass spectrometry approaches validate guanosine monophosphate synthetase as essential for Mycobacterium tuberculosis growth. |
| Q30425739 | Helicobacter pylori relies primarily on the purine salvage pathway for purine nucleotide biosynthesis |
| Q34655078 | Inactivation of the Rgg2 transcriptional regulator ablates the virulence of Streptococcus pyogenes |
| Q55070411 | Live Attenuated Tularemia Vaccines for Protection Against Respiratory Challenge With Virulent F. tularensis subsp. tularensis. |
| Q30409782 | Live attenuated mutants of Francisella tularensis protect rabbits against aerosol challenge with a virulent type A strain |
| Q30222801 | Live attenuated tularemia vaccines: recent developments and future goals |
| Q30423136 | Members of the Francisella tularensis phagosomal transporter subfamily of major facilitator superfamily transporters are critical for pathogenesis |
| Q35745572 | Mutational Analysis of the Chlamydia muridarum Plasticity Zone |
| Q33615261 | Phagosomal retention of Francisella tularensis results in TIRAP/Mal-independent TLR2 signaling |
| Q30424747 | Role of TLR signaling in Francisella tularensis-LPS-induced, antibody-mediated protection against Francisella tularensis challenge |
| Q35924128 | Signature-tagged mutagenesis of Vibrio vulnificus. |
| Q27499012 | Systems approach to investigating host-pathogen interactions in infections with the biothreat agent Francisella. Constraints-based model of Francisella tularensis |
| Q30356398 | The antibiotic potential of prokaryotic IMP dehydrogenase inhibitors |
| Q30413938 | The reduced genome of the Francisella tularensis live vaccine strain (LVS) encodes two iron acquisition systems essential for optimal growth and virulence |
| Q35075784 | Tryptophan prototrophy contributes to Francisella tularensis evasion of gamma interferon-mediated host defense |
| Q38838074 | Tularemia vaccines. |
| Q35095362 | Vaccines against tularemia |
| Q37451520 | Working toward the future: insights into Francisella tularensis pathogenesis and vaccine development |
Search more.